Genotyping of C.elegans mutants - CRISPR/Cas9 of all GPCR and neuropeptide genes
Ontology highlight
ABSTRACT: CRISPR/Cas9 genome editing was used to disrupt nearly all the GPCR and neuropeptide genes from C. elegans genome. Multiple genes were disrupted in each strain for the purpose of screening. The genotype is the list of targeted genes
INSTRUMENT(S): Illumina HiSeq 4000
ORGANISM(S): Caenorhabditis elegans
SUBMITTER: Johan Henriksson
PROVIDER: E-MTAB-12983 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA